Clinical Trials Browser

Phase 1/2 × Esophageal Neoplasms × Albumin-Bound Paclitaxel × Clear all

NCT04068896 2025-05-29

Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy

DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT04278287 2024-12-13

Chemoradiotherapy in Unresectable Esophageal Cancer

Phase 1/2 Recruiting

105 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT04460066 2022-05-04

A Study of Anti-PD-L1 Antibody in Neoadjuvant Chemotherapy of Esophageal Squamous Cell Carcinoma.

Phase 1/2 Unknown

70 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT02273713 2017-05-31

ACTION

Phase 1/2 Completed

154 enrolled

Gastrointestinal

Esophageal Neoplasms, Neoplasm Metastasis